Bird Flu > Bird Flu News > CytoGenix, Inc. Initiates Ferret Testing Expecting Positive Results for Avian Flu Vaccine Study

CytoGenix, Inc. Initiates Ferret Testing Expecting Positive Results for Avian Flu Vaccine Study
NEW BRAUNFELS, Texas----CytoGenix, Inc. today announced that it has initiated the process of testing CytoGenix’s novel liner DNA technology on ferrets, with the expectations of a positive result, furthering the development of the vaccine candidate.